Postoperative dexamethasone does not reduce risk of adverse events following major non-cardiac surgery
1. This phase III drug trial showed that dexamethasone does not significantly reduce risk of adverse events and death following ...
Tag: systemic inflammation
Tocilizumab may improve survival in COVID-19 patients with hypoxia and systemic inflammation
1. Compared to usual care, fewer patients in the tocilizumab group died within 28 days of randomization. 2. Patients allocated ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
